Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)

Clinical trial NCT04140305 · TERMINATED

Trial details

NCT number: NCT04140305
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2020-01-16
Primary completion: 2025-05-15
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.